Effects of Thoracic Kinesio Taping on COPD Patients

COPD Clinical Trial

Official title:

Effects of Thoracic Kinesio Taping on Pulmonary Functions, Respiratory Muscle Strength and Functional Capacity in COPD Patients

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03496376
• Other study ID #: 1925-GOA
• Status: Completed
• Phase: N/A
• Start date: May 2, 2017
• Est. completion date: June 7, 2018

Study information

• Verified date: July 2018
• Source: Dokuz Eylul University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purpose of this study was to investigate the effect of kinseio taping on functional capacity, pulmonary functions, respiratory muscle strength, severity of dyspnea, severity of fatigue in Chronic Obstructive Pulmonary Disease (COPD). Assessment of patients was done baseline and 6th week.

Eligible patients for the study randomly allocated to Kinesio Taping Group (KTG), or Control Group (CG). Both groups received three different deep breathing exercises (diaphragmatic, thoracic, and lateral basal), each consisting of three sets of 10 repetitions, with 30 seconds of rest between each set. KTG also received thoracic kinesio taping application.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 27
• Est. completion date: June 7, 2018
• Est. primary completion date: May 31, 2018
• Accepts healthy volunteers: No
• Gender: All
• Age group: 40 Years to 80 Years

Eligibility

Inclusion Criteria:

• aged 40 years and older,

• having stage II-III COPD diagnosis according to GOLD system and BODE Index by chest physician,

• unwilling to participate in any kind of pulmonary rehabilitation program for COPD,

• able to read, write, and understand Turkish; and

• willing and able to attend the study.

Exclusion Criteria:

• being in COPD exacerbation period,

• having neurological or musculoskeletal problems that would affect physical mobility,

• having unstable, severe heart disease(s) (heart failure, unstable hypertension, previous angina pectoris or myocardial infarction, heart valve problems),

• having scar, lesion or incision in the area of kinesio tape application,

• previous use of kinesio tape,

• having skin sensitivity against kinesio tape,

• malignancy,

• having mental and cognitive disorders that would affect cooperation.

Related Conditions & MeSH terms

• COPD

Intervention

Other:
• Kinesio Taping
The material used for thoracic kinesio taping application was Kinesio® Tex Gold™ (Kinesio Holding. Patients were instructed to sit upright on an armless chair with no back support, with knees flexed to 90 degrees, feet on the floor and arms relaxed. Kinesio tape was applied anteriorly and posteriorly to facilitate respiratory muscles (primarily diaphragm) along the subcostal area. Additionally, two more kinesio tapes were applied to upper trapezius and scalene muscles' area which lies between neck and acromion at both sides (left and right).
• Deep Breathing Exercises
Three different deep breathing exercises (diaphragmatic, thoracic, and lateral basal), each consisting of three sets of 10 repetitions, with 30 seconds of rest between each set.

Locations

Country	Name	City	State
Turkey	Dokuz Eylül Üniversitesi School of Physical Therapy and Rehabilitation	Izmir

Sponsors (1)

Lead Sponsor	Collaborator
Dokuz Eylul University

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Change in functional capacity	Six-minute walk test (6MWT) is a valid, reliable and useful test for assessing functional capacity of COPD patients. This test assesses distance walked over 6 minutes as a sub-maximal test of aerobic capacity/endurance.	Baseline, 6th week
Secondary	Change in pulmonary functions	Pulmonary function test (PFT) is a generic term used to indicate a battery of studies or maneuvers that may be performed using standardized equipment to measure lung function.	Baseline, 6th week
Secondary	Change in respiratory muscle strength	Measurement of respiratory muscle strength is useful in order to detect respiratory muscle weakness and to quantify its severity. Respiratory muscle strength is assessed by mouth pressures sustained for 1 s during maximas static manoeuvre against a closed shutter.	Baseline, 6th week
Secondary	Change in severity of dyspnoea	Modified Medical Research Council (mMRC) dyspnea scale is a valid and reliable test for measuring the severity of dyspnea of COPD patients. This scale ranges from 0 to 4. A higher value represents a worse outcome.	Baseline, 6th week
Secondary	Change in severity of fatigue	Modified Borg Scale (MBS) is a useful scale for severity of fatigue. This scale ranges from 0 to 10. A higher value represents a worse outcome (0=not at all, 10=maximal).	Baseline, 6th week